Grüter, Thomas
Ott, Anthonina
Meyer, Wolfgang
Jarius, Sven
Kinner, Markus
Motte, Jeremias
Pitarokoili, Kalliopi
Gold, Ralf
Komorowski, Lars
Ayzenberg, Ilya http://orcid.org/0000-0002-6009-792X
Article History
Received: 26 August 2019
Revised: 10 October 2019
Accepted: 26 October 2019
First Online: 14 November 2019
Compliance with ethical standards
:
: TG received travel reimbursement from Sanofi Genzyme and Biogen Idec, none related to this manuscript. AO is employee of EUROIMMUN AG, a company that develops, manufactures and markets serological assays for the determination of autoantibodies. WM is employee of EUROIMMUN AG, a company that develops, manufactures and markets serological assays for the determination of autoantibodies. SJ reports no conflicts of interest. MK received a travel grant from Biogen idec, not related to this study. JM received travel grants from Biogen Idec, Novartis AG, Teva and Eisai GmbH, his research is funded by Klaus Tschira Foundation and Ruhr-University, Bochum (FORUM-program); none related to this work. KP received travel funding and speaker honoraria from Biogen Idec, Novartis and Bayer Schering Pharma and funding from the Ruhr-University, Bochum (FORUM-Program), none related to this manuscript. RG serves on scientific advisory boards for Teva Pharmaceutical Industries Ltd., Biogen Idec, Bayer Schering Pharma, and Novartis; has received speaker honoraria from Biogen Idec, Teva Pharmaceutical Industries Ltd., Bayer Schering Pharma, and Novartis; serves as editor for Therapeutic Advances in Neurological Diseases and on the editorial boards of Experimental Neurology and the Journal of Neuroimmunology; and receives research support from Teva Pharmaceutical Industries Ltd., Biogen Idec, Bayer Schering Pharma, Genzyme, Merck Serono, and Novartis, none related to this manuscript. LK is employee of EUROIMMUN AG, a company that develops, manufactures and markets serological assays for the determination of autoantibodies. IA received travel grants from Biogen Idec and Guthy-Jackson Charitable Foundation, served on scientific advisory boards for Roche and Alexion and received research support from Chugai Pharma, none related to this manuscript.
: The study has been approved by the local ethics committee (Ethik-Kommission Ruhr-Universität Bochum) and have therefore been performed in accordance with the ethical standards laid down in the 1964 Declaration of Helsinki and its later amendments. All persons gave their informed consent prior to their inclusion in the study.